CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
Clinical trial NCT06752785 · RECRUITING
Trial details
- NCT number
- NCT06752785
- Sponsor
- Guangzhou Women and Children's Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.